glp-1 receptor agonist for weight loss GLP1 Agonists—Effects beyond Obesity and Diabetes Study finds GLP-1 receptor agonists

Description

This treatment results in lowered TNF- [8] and IL-17 levels [8], blocks NF-B signaling pathways [8,55], and decreases both C-reactive protein [19] and IL-6 levels [19]

The newest chapter involves dual agonists

The pathogenesis originates from an imbalance in hepatic lipid homeostasis, where excessive triglyceride accumulation results from increased lipid influx, enhanced de novo lipogenesis, and impaired lipid export or oxidation

Individuals should be counseled to avoid refined carbohydrates (i.e., refined grains, flour, starches, sugars), sugar-sweetened beverages, red and processed meats, and most fast foods, ultra-processed sweets, and savory snacks (Table 6)

Accumulated evidence has shown that the RAAS is no longer considered to act just as an endocrine system, but also as a paracrine, autocrine and intracrine system